Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baymag is a leading producer of high-purity magnesium oxide and magnesium hydroxide, sourced from one of the world's purest magnesite deposits in the Canadian Rockies. The company provides specialized grades of magnesium compounds for the pharmaceutical and food industries, adhering to USP and FCC standards for use as active pharmaceutical ingredients and excipients. Based in Calgary, Alberta, Baymag operates a vertically integrated business model encompassing mining, calcining, and processing. Its products are widely utilized in the production of antacids, laxatives, and mineral supplements. As a subsidiary of the Refratechnik Group, Baymag serves a global market with high-quality mineral products for both industrial and healthcare applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baymag.